The distinct population of endothelial cells that line blood vessels in the insulin-producing "islets" of the human pancreas ...

have identified a previously unknown signaling mechanism that enables pancreatic cancer cells to evade immune defenses and sustain tumor growth, as reported by the Taipei Times. Their findings ...

Their study, titled Intercellular TIMP-1-CD63 signalling directs the evolution of immune escape and metastasis in KRAS-mutated pancreatic cancer cells, was based on laboratory experiments using mice, ...

More than 67,000 Americans will be diagnosed with pancreatic cancer this year. Learn more about the disease and how PanCAN can help.

Dr. Marwan G. Fakih explains that KRAS mutations, found in 45% of patients with colorectal cancer, include the rare KRAS G12C mutation, leading to Lumakras approval.

The Phase II eNRGy trial showed durable antitumor activity with zenocutuzumab (Bizengri) in patients with NRG1 ...

Feb. 12, 2025 — A new blood test could help doctors detect pancreatic cancer earlier, potentially improving survival rates for one of the deadliest ...

Poor appetite is a common nutritional challenge for patients with pancreatic cancer. Sometimes surgery, prescription drugs or the cancer itself can change the way food tastes or cause the patient’s ...

Interrupting signals exchanged between tumors and the nervous system could become a critical pillar of cancer care ...